Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Burger

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Bone Marrow Transplantation|September 6, 2016
Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLLI F Khouri, D Sui, E J Jabbour, et al.
Leukemia|June 9, 2017
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLLJ R Brown, P Hillmen, S O'Brien, et al.
NPJ Vaccines|November 26, 2022
Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidatesE I M M Reiss, M M van Haaren, J van Schooten, et al.
Research Square|February 23, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsP Maisonnasse, Y Aldon, A Marc, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Bone Marrow Transplantation|September 6, 2016
Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLLI F Khouri, D Sui, E J Jabbour, et al.
Leukemia|June 9, 2017
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLLJ R Brown, P Hillmen, S O'Brien, et al.
NPJ Vaccines|November 26, 2022
Fine-mapping the immunodominant antibody epitopes on consensus sequence-based HIV-1 envelope trimer vaccine candidatesE I M M Reiss, M M van Haaren, J van Schooten, et al.
Research Square|February 23, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsP Maisonnasse, Y Aldon, A Marc, et al.
Pageof 4